We are live on ! Find out more

2,009 hedge funds and large institutions have $114B invested in Merck in 2017 Q4 according to their latest regulatory filings, with 232 funds opening new positions, 753 increasing their positions, 821 reducing their positions, and 127 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 232 | Existing positions closed: 127

4% more funds holding

Funds holding: 1,9242,009 (+85)

0.61% less ownership

Funds ownership: 78.3%77.69% (-0.61%)

8% less repeat investments, than reductions

Existing positions increased: 753 | Existing positions reduced: 821

9% less call options, than puts

Call options by funds: $1.16B | Put options by funds: $1.28B

13% less capital invested

Capital invested by funds: $130B → $114B (-$16.8B)

39% less funds holding in top 10

Funds holding in top 10: 11771 (-46)

Holders
2,009
Holders Change
+85
Holders Change %
+4.42%
% of All Funds
45.56%
Holding in Top 10
71
Holding in Top 10 Change
-46
Holding in Top 10 Change %
-39.32%
% of All Funds
1.61%
New
232
Increased
753
Reduced
821
Closed
127
Calls
$1.16B
Puts
$1.28B
Net Calls
-$119M
Net Calls Change
-$461M
Name Holding Trade Value Shares
Change
Change in
Stake
CIM
601
Cambria Investment Management
California
$5.75M +$1.35M +24,366 +29%
DY
602
Dowling & Yahnke
California
$5.74M -$248K -4,472 -4%
BAM
603
Barrett Asset Management
New York
$5.72M -$38.1K -687 -0.6%
BIAS
604
Beacon Investment Advisory Services
New Jersey
$5.71M -$1.68M -30,248 -22%
CC
605
Capital Counsel
New York
$5.71M +$3.99K +72 +0.1%
MDCM
606
Morgan Dempsey Capital Management
Wisconsin
$5.71M +$1.61M +29,041 +38%
MYAM
607
Meiji Yasuda Asset Management
Japan
$5.68M -$237K -4,278 -4%
CI
608
Cigna Investments
Connecticut
$5.68M -$1.41M -25,456 -19%
CAM
609
Cypress Asset Management
Texas
$5.67M -$231K -4,161 -4%
CB
610
Community Bank
New York
$5.65M +$356K +6,418 +6%
GCM
611
Gabalex Capital Management
New York
$5.63M -$2.9M -52,400 -33%
MCTIC
612
MacGuire Cheswick & Tuttle Investment Counsel
Connecticut
$5.63M -$233K -4,206 -4%
IA
613
Icon Advisers
Colorado
$5.62M -$151K -2,725 -3%
UR
614
USCA RIA
Texas
$5.61M -$260K -4,685 -4%
PCM
615
Parsons Capital Management
Rhode Island
$5.58M -$37.3K -672 -0.6%
APFBOT
616
Amica Pension Fund Board of Trustees
Rhode Island
$5.58M -$1.27M -22,841 -18%
OIM
617
Opus Investment Management
Massachusetts
$5.54M
CB
618
Chemical Bank
Michigan
$5.48M +$114K +2,057 +2%
Carson Wealth (CWM LLC)
619
Carson Wealth (CWM LLC)
Nebraska
$5.46M +$448K +8,087 +9%
CWM
620
Calamos Wealth Management
Illinois
$5.46M -$679K -12,245 -11%
BCM
621
Beddow Capital Management
Wyoming
$5.43M -$95.3K -1,719 -2%
Cerity Partners
622
Cerity Partners
New York
$5.42M -$44.8K -808 -0.8%
BIA
623
Barry Investment Advisors
Massachusetts
$5.42M +$13.5K +243 +0.2%
GA
624
GFS Advisors
Texas
$5.39M +$2.39M +43,086 +75%
ACM
625
Argyle Capital Management
Pennsylvania
$5.38M +$259K +4,663 +5%

MRK Hedge Fund Activity: Q4 2017 in Review

2,009 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2017, worth a combined $114B — down 13% from $130B a quarter earlier.

Buyers outnumbered sellers: 232 funds opened new MRK positions and 127 closed out — a net gain of 105 holders — while 753 added to existing stakes and 821 trimmed.

The largest buyer was Franklin Resources, adding an estimated $926M. The largest seller was Wellington Management Group, cutting an estimated $669M.

  • 2,009 institutional investors held Merck (MRK) as of Q4 2017, up from 1,924 in Q3 2017.
  • Funds reported $114B of Merck stock for Q4 2017, down 13% quarter-over-quarter.
  • 232 funds opened new Merck positions in Q4 2017 and 127 closed out, a net change of +105 holders.
  • The largest Merck buyer in Q4 2017 was Franklin Resources, an estimated $926M added.
  • The largest Merck seller in Q4 2017 was Wellington Management Group, an estimated $669M sold.

Based on aggregated 13F filings for Q4 2017.